Outpatient Facility Coding Alert - 2005 Issue 33
PHYSICIANS: Brakes Applied To Drug Bidding Program
Subscribe or sign in to view the full article.
Article Overview
This article covers a CMS delay in the Competitive Acquisition Program for Part B drugs, along with industry criticism from physicians and oncology stakeholders. It is relevant to readers tracking Medicare drug payment policy, CMS rulemaking, and operational concerns affecting community oncology practices and vendors. The piece focuses on the status of the program, the reasons for pushback, and the general types of implementation issues raised by providers.
Why This Topic Matters
Changes to Medicare drug acquisition and billing policy can affect how physician practices obtain drugs, work with vendors, and manage reimbursement workflows. Understanding the CMS response and stakeholder concerns helps readers evaluate whether the program could affect practice operations and patient care.
What You Will Learn
- The status of CMS action on the Competitive Acquisition Program for Part B drugs.
- The broad categories of concerns raised by physicians and oncology stakeholders.
- Why vendors and practice operations were central to the discussion.
- How the article frames the potential impact on community oncology workflows.
Who Should Read This
- Physicians
- Oncology practices
- Medical coders
- Billing and reimbursement staff
- Healthcare administrators
- Policy analysts
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com